Michael A. Carrier

Rutgers Law School

Distinguished Professor

217 North Fifth Street

Camden, NJ 08102-1203

United States

SCHOLARLY PAPERS

154

DOWNLOADS
Rank 708

SSRN RANKINGS

Top 708

in Total Papers Downloads

43,541

SSRN CITATIONS
Rank 10,246

SSRN RANKINGS

Top 10,246

in Total Papers Citations

34

CROSSREF CITATIONS

88

Scholarly Papers (154)

1.

Copyright and Innovation: The Untold Story

2012 Wisconsin Law Review 891
Number of pages: 72 Posted: 04 Jul 2012 Last Revised: 04 Dec 2012
Michael A. Carrier
Rutgers Law School
Downloads 8,200 (909)
Citation 1

Abstract:

Loading...

copyright, innovation, music, peer-to-peer (p2p), venture capital, napster, Innovator's Dilemma, record labels, SOPA, PIPA, statutory damages, personal liability

2.

A Roadmap to the Smartphone Patent Wars and FRAND Licensing

CPI Antitrust Chronicle, Vol. 2, April 2012
Number of pages: 7 Posted: 04 May 2012
Michael A. Carrier
Rutgers Law School
Downloads 3,369 (4,255)
Citation 1

Abstract:

Loading...

Smartphones, patents, patent wars, standards, RAND, FRAND, antitrust

3.

Cabining Intellectual Property Through a Property Paradigm

Number of pages: 145 Posted: 30 Apr 2004
Michael A. Carrier
Rutgers Law School
Downloads 1,895 (10,986)
Citation 2

Abstract:

Loading...

Intellectual property, property, propertization, patent, copyright, trademark, right of publicity

4.

Against Cyberproperty

Berkeley Technology Law Journal, Vol. 22, 2007
Number of pages: 36 Posted: 25 Apr 2007 Last Revised: 06 Apr 2008
Michael A. Carrier and Greg Lastowka
Rutgers Law School and Rutgers School of Law
Downloads 1,191 (22,495)

Abstract:

Loading...

cyberproperty, property, cyberspace, Locke, Hegel, utilitarianism, spam, electronic invasion, copyright

5.

The Untold EpiPen Story: How Mylan Hiked Prices by Blocking Rivals

102 Cornell Law Review Online 53 (2017)
Number of pages: 20 Posted: 21 Sep 2016 Last Revised: 01 Feb 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 1,098 (25,360)
Citation 1

Abstract:

Loading...

EpiPen, Mylan, antitrust, settlement, citizen petition, exclusive dealing, Teva

6.

Innovation for the 21st Century: Harnessing the Power of Intellectual Property and Antitrust Law

Oxford University Press, 2009
Number of pages: 16 Posted: 27 Mar 2009
Michael A. Carrier
Rutgers Law School
Downloads 829 (37,656)

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

7.

Using Antitrust Law to Challenge Turing's Daraprim Price Increase

31 Berkeley Technology Law Journal 1379 (2017)
Number of pages: 30 Posted: 29 Jan 2016 Last Revised: 14 Jul 2017
Michael A. Carrier, Nicole Levidow and Aaron S. Kesselheim
Rutgers Law School, Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics and Brigham and Women's Hospital/Harvard Medical School
Downloads 702 (47,172)

Abstract:

Loading...

Turing, Shkreli, antitrust, monopolization, drugs, pharmaceuticals, Daraprim, pyrimethamine

8.

A Real-World Analysis of Pharmaceutical Settlements: The Missing Dimension of Product-Hopping

Florida Law Review, Vol. 62, 2010
Number of pages: 28 Posted: 14 Apr 2010 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 702 (47,172)
Citation 3

Abstract:

Loading...

patent, antitrust, settlement, product hopping, drugs, pharmaceuticals, Hatch Waxman, reverse payments

9.

Two Puzzles Resolved: Of the Schumpeter - Arrow Stalemate and Pharmaceutical Innovation Markets

Iowa Law Review, Vol. 93, 2008
Number of pages: 58 Posted: 09 Apr 2007 Last Revised: 02 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 697 (47,668)

Abstract:

Loading...

antitrust, innovation market, schumpeter, arrow, market structure, innovation, mergers, patents, pharmaceuticals

10.

The Pirate Bay, Grokster, and Google

Journal of Intellectual Property Rights, Vol. 15, pp. 7-18, January 2010
Number of pages: 12 Posted: 04 Oct 2009 Last Revised: 27 Oct 2012
Michael A. Carrier
Rutgers Law School
Downloads 675 (49,729)
Citation 2

Abstract:

Loading...

The Pirate Bay, Google, Grokster, copyright, file-sharing, P2P, BitTorrent, secondary liability, piracy, infringement

11.

Patent Assertion Entities: Six Actions the Antitrust Agencies Can Take

CPI Antitrust Chronicle, Winter 2013, Vol. 1 No. 2
Number of pages: 12 Posted: 31 Jan 2013
Michael A. Carrier
Rutgers Law School
Downloads 665 (50,715)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust

12.

RAND Patents and Exclusion Orders: Submission of 19 Economics and Law Professors to the International Trade Commission

Santa Clara Univ. Legal Studies Research Paper No. 07-12, UC Berkeley Public Law Research Paper No. 2102865
Number of pages: 13 Posted: 10 Jul 2012
Santa Clara University - School of Law, University of California, Berkeley - Department of Economics, University of California, Berkeley - Haas School of Business, University of Minnesota Law School, Notre Dame Law School, Syracuse University College of Law, Santa Clara University - School of Law, University of California, Irvine School of Law, Pennsylvania State University - Mary Jean and Frank P. Smeal College of Business Administration, Rutgers Law School, University of Utah - S.J. Quinney College of Law, University of Georgia School of Law, Villanova University Charles Widger School of Law, New York University School of Law, University of San Diego School of Law, Duke University School of Law, New York University School of Law, Centre of Excellence GOVTRUST, University of Antwerp, Belgium and University of Nebraska - College of Law
Downloads 653 (51,934)
Citation 1

Abstract:

Loading...

13.

No, RIAA, It's Not the End of the World for Musicians

University of Missouri-Kansas City Law Review, 2014
Number of pages: 16 Posted: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 621 (55,467)

Abstract:

Loading...

music, musicians, copyright, GarageBand, Twitter, YouTube, Topspin, Bandcamp, CD Baby Pro, TuneCore, Kickstarter, Indiegogo, Songkick, Bandsintown

14.

Resolving the Patent-Antitrust Paradox Through Tripartite Innovation

Number of pages: 65 Posted: 19 Feb 2003
Michael A. Carrier
Rutgers Law School
Downloads 579 (60,490)
Citation 3

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

15.

What You Need to Know About Standard Essential Patents

Competition Policy International (Vol. 8, No. 2, 2014)
Number of pages: 10 Posted: 27 Aug 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 568 (62,148)

Abstract:

Loading...

Standard essential patents, SEPs, RAND, FRAND, antitrust, injunctions

16.

Product Hopping: A New Framework

92 Notre Dame Law Review, 167 (2016)
Number of pages: 65 Posted: 16 Mar 2016 Last Revised: 25 Feb 2017
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 562 (62,867)
Citation 2

Abstract:

Loading...

product hopping, pharmaceuticals, drugs, antitrust, no economic sense, reformulations, Hatch Waxman, state DPS laws

17.

Unsettling Drug Patent Settlements: A Framework for Presumptive Illegality

Michigan Law Review, Vol. 108
Number of pages: 44 Posted: 11 Mar 2009 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 539 (66,230)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

18.

Biologics: The New Antitrust Frontier

2018 U. Ill. L. Rev. 1 (2018)
Number of pages: 70 Posted: 08 Jun 2017 Last Revised: 31 Jan 2018
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 525 (68,515)

Abstract:

Loading...

biologics, BPCIA, antitrust, settlements, product hopping, REMS, citizen petitions, disparagement, collusion

19.

Citizen Petitions: Long, Late-Filed, and At-Last Denied

66 American University Law Review 305 (2016)
Number of pages: 48 Posted: 30 Aug 2016 Last Revised: 02 Jan 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 525 (68,515)
Citation 4

Abstract:

Loading...

citizen petition, pharmaceuticals, drugs, 505(q), brands, generics, Copaxone, Mirena, Doryx, EpiPen

20.

The Rule of Reason: An Empirical Update for the 21st Century

George Mason Law Review, Vol. 16, No. 827, 2009
Number of pages: 11 Posted: 29 Sep 2009 Last Revised: 04 Oct 2009
Michael A. Carrier
Rutgers Law School
Downloads 474 (77,630)
Citation 3

Abstract:

Loading...

antitrust, rule of reason, balancing, anticompetitive effects, procompetitive justifications

21.

Payment after Actavis

100 Iowa Law Review 7 (2014)
Number of pages: 43 Posted: 02 Apr 2014 Last Revised: 30 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 458 (80,933)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, poison pill, acceleration clauses, authorized generics

22.

A Tort-Based Causation Framework for Antitrust Analysis

Antitrust Law Journal, Forthcoming
Number of pages: 26 Posted: 15 Oct 2011 Last Revised: 17 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 457 (81,116)
Citation 1

Abstract:

Loading...

causation, antitrust, tort, monopolization, antitrust injury

23.

Big Tech, Antitrust, and Breakup

Georgetown Journal of International Affairs (Jan. 2020)
Number of pages: 4 Posted: 27 May 2020
Michael A. Carrier
Rutgers Law School
Downloads 442 (84,369)
Citation 1

Abstract:

Loading...

antitrust, Big Tech, Amazon, Apple, Facebook, Google

24.

How Not to Apply the Rule of Reason: The O’Bannon Case

114 Michigan Law Review First Impressions 73 (2015)
Number of pages: 8 Posted: 11 Oct 2015 Last Revised: 02 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 436 (85,729)

Abstract:

Loading...

NCAA, O'Bannon, college sports, amateurism, antitrust, Rule of Reason, less restrictive alternatives, balancing

25.

Citizen Petitions: An Empirical Study

Cardozo Law Review, Forthcoming
Number of pages: 46 Posted: 04 Jun 2012 Last Revised: 30 Jul 2013
Michael A. Carrier and Daryl Wander
Rutgers Law School and affiliation not provided to SSRN
Downloads 423 (88,864)

Abstract:

Loading...

citizen petitions, pharmaceutical, patent, antitrust, FDA, generics

26.

Google and Antitrust: Five Approaches to an Evolving Issue

Harvard Journal of Law & Technology Occasional Paper Series - July 2013
Number of pages: 14 Posted: 02 Aug 2013
Michael A. Carrier
Rutgers Law School
Downloads 420 (89,553)

Abstract:

Loading...

Google, antitrust, search neutrality, Google Book search, FTC

27.

Playing Both Sides: Branded Sales, Generic Drugs, and Antitrust Policy

Stanford Law and Economics Olin Working Paper No. 533, 71 Hastings Law Journal 307 (2020), Rutgers Law School Research Paper
Number of pages: 52 Posted: 12 Mar 2019 Last Revised: 21 Feb 2020
Michael A. Carrier, Mark A. Lemley and Shawn P. Miller
Rutgers Law School, Stanford Law School and University of San Diego School of Law
Downloads 398 (95,238)

Abstract:

Loading...

antitrust, mergers, pharmaceuticals, empirical studies, generics

28.

Unraveling the Patent-Antitrust Paradox

University of Pennsylvania Law Review, Vol. 150, January 2002
Number of pages: 94 Posted: 30 Apr 2002
Michael A. Carrier
Rutgers Law School
Downloads 397 (95,510)
Citation 1

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

29.

Refusals to License Intellectual Property after Trinko

DePaul Law Review, Vol. 55, p. 1191, 2006
Number of pages: 20 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 352 (109,502)
Citation 1

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

30.

Why Antitrust Should Defer to the Intellectual Property Rules of Standard-Setting Organizations: A Commentary on Teece & Sherry

Minnesota Law Review, Vol. 87, p. 2019, 2003
Number of pages: 20 Posted: 05 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 352 (109,502)

Abstract:

Loading...

antitrust, intellectual property, standards, standard-setting organizations

31.

Why the 'Scope of the Patent' Test Cannot Solve the Drug Patent Settlement Problem

Stanford Technology Law Review, Vol. 16, No. 1, 2012
Number of pages: 8 Posted: 15 Sep 2012
Michael A. Carrier
Rutgers Law School
Downloads 337 (115,020)
Citation 3

Abstract:

Loading...

patents, antitrust, pharmaceuticals, settlements, patent scope

32.

Sharing, Samples, and Generics: An Antitrust Framework

103 Cornell Law Review 1 (2017)
Number of pages: 64 Posted: 04 Jun 2017 Last Revised: 22 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 336 (115,413)

Abstract:

Loading...

antitrust, patent, pharmaceuticals, drugs, samples, REMS

33.

Antitrust in the Pharmaceutical Sector: An Overview of U.S. Case Law

e-Competitions Bulletin, No. 88026, Nov. 2018
Number of pages: 10 Posted: 11 Nov 2018
Michael A. Carrier
Rutgers Law School
Downloads 326 (119,243)

Abstract:

Loading...

Pharmaceutical, Antitrust, Settlements, Product Hopping, Sample Denials, Citizen Petitions, Rebates/Bundling

34.

SOPA, PIPA, ACTA, TPP: An Alphabet Soup of Innovation-Stifling Copyright Legislation and Agreements

Northwestern Journal of Technology and Intellectual Property, Vol. 11, No. 2, 2013
Number of pages: 14 Posted: 07 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 325 (119,628)

Abstract:

Loading...

copyright, innovation, secondary liability, Stop Online Piracy Act (SOPA), PROTECT IP Act (PIPA), Anti-Counterfeiting Trade Agreement (ACTA), Trans-Pacific Partnership Agreement (TPP)

35.

Three Challenges for Pharmaceutical Antitrust

59 Santa Clara Law Review 613 (2020) (symposium), Rutgers Law School Research Paper
Number of pages: 25 Posted: 27 Mar 2019 Last Revised: 23 Feb 2020
Michael A. Carrier
Rutgers Law School
Downloads 310 (125,768)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, settlements, product hopping, citizen petitions, sample denials, REMS

36.

Pharmaceutical Antitrust: What the Trump Administration Can Do

Concurrences: Competition Law Review 63 (No. 4, 2016)
Number of pages: 3 Posted: 05 Dec 2016
Michael A. Carrier
Rutgers Law School
Downloads 303 (128,896)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, patents, FDA, settlements, product hopping, REMS

37.

Brief Amici Curiae of 118 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Petitioners

Supreme Court amicus brief in FTC v. Watson, 2013
Number of pages: 62 Posted: 30 Jan 2013
Michael A. Carrier and Mark A. Lemley
Rutgers Law School and Stanford Law School
Downloads 280 (140,005)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Hatch Waxman, reverse payments, exclusion payments, Androgel

38.

Pharmaceutical Antitrust Complexity

CPI Antitrust Chronicle (Nov. 2014)
Number of pages: 12 Posted: 25 Nov 2014
Michael A. Carrier
Rutgers Law School
Downloads 262 (149,868)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, complexity, settlements, product hopping, generics

39.

The Real Rule of Reason: Bridging the Disconnect

Brigham Young University Law Review, Vol. 1999, p. 1265
Number of pages: 102 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 255 (153,955)
Citation 3

Abstract:

Loading...

Rule of Reason, balancing, anticompetitive effects, procompetitive justifications

40.

Solving the Drug Settlement Problem: The Legislative Approach

Rutgers Law Journal, Vol. 41, pp. 81, 2009, Lawyers, Drugs & Money Symposium, Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry
Number of pages: 21 Posted: 23 Dec 2009 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 254 (154,571)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

41.

An Antitrust Framework for False Advertising

Iowa Law Review, Forthcoming, Rutgers Law School Research Paper, Harvard Public Law Working Paper No. 20-16
Number of pages: 44 Posted: 27 May 2020 Last Revised: 17 Jun 2021
Michael A. Carrier and Rebecca Tushnet
Rutgers Law School and Harvard Law School
Downloads 242 (162,099)

Abstract:

Loading...

antitrust, false advertising, monopoly, biosimilars

42.

Five Solutions to the REMS Patent Problem

97 Boston University Law Review 1661 (2017)
Number of pages: 47 Posted: 05 Jul 2017 Last Revised: 05 Oct 2017
Michael A. Carrier and Brenna Sooy
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 242 (162,099)

Abstract:

Loading...

Patent, Drugs, Pharmaceuticals, REMS, FDA

43.

Pleading Standards: The Hidden Threat to Actavis

91 New York University Law Review Online 31 (2016)
Number of pages: 12 Posted: 21 May 2016 Last Revised: 22 May 2016
Michael A. Carrier
Rutgers Law School
Downloads 239 (164,056)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, pleading, Twombly, Iqbal, Actavis, Effexor, Lipitor

44.

The D.C. Circuit’s Excessively High Causation Standard in Rambus

Number of pages: 25 Posted: 08 Apr 2010 Last Revised: 25 May 2014
Michael A. Carrier
Rutgers Law School
Downloads 238 (164,740)

Abstract:

Loading...

Antitrust, Standard-Setting, Causation, Rambus, Monopolization, Discon

45.

Of Trinko, Tea Leaves, and Intellectual Property

Journal of Corporation Law, Vol. 31, 2005
Number of pages: 17 Posted: 28 Feb 2006
Michael A. Carrier
Rutgers Law School
Downloads 230 (170,229)

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

46.

U.S. Court Upholds Antitrust Action Against Patent Troll

e-Competitions Bulletin, No. 73428, May 2015
Number of pages: 5 Posted: 13 Jun 2015
Michael A. Carrier
Rutgers Law School
Downloads 225 (173,834)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust, Intellectual Ventures, Capital One

47.

An Antitrust Framework for Climate Change

Northwestern Journal of Technology and Intellectual Property, Vol. 9, No. 8, p. 513, 2011
Number of pages: 22 Posted: 10 Sep 2011
Michael A. Carrier
Rutgers Law School
Downloads 225 (173,834)

Abstract:

Loading...

antitrust, climate change, markets, standards, patent pools, Smart Grid, Eco-Patent Commons, Green Xchange

48.

Vote Counting, Technology, and Unintended Consequences

St. John's Law Review, Vol. 69, 2005
Number of pages: 43 Posted: 30 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 211 (184,663)

Abstract:

Loading...

Electronic voting, vote counting, computerization, technology, HAVA, 2004 election

49.

Post-Grant Opposition: A Proposal and a Comparison to the America Invents Act

UC Davis Law Review, Vol. 45 (2011)
Number of pages: 33 Posted: 14 Mar 2011 Last Revised: 11 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 203 (191,428)

Abstract:

Loading...

patents, patent reform, post-grant opposition, America Invents Act

50.

Pharmaceutical Antitrust: What the Biden Administration Can Do

Concurrences, N° 1-2021, Rutgers Law School Research Paper No. Forthcoming
Number of pages: 4 Posted: 27 Jan 2021
Michael A. Carrier
Rutgers Law School
Downloads 202 (192,293)

Abstract:

Loading...

Antitrust, pharmaceuticals, drugs, pay-for-delay settlements, product hopping, biosimilars

51.
Downloads 199 (194,907)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP

52.
Downloads 198 (195,821)
Citation 1

The Four-Step Rule of Reason

33 Antitrust 50 (2019), Rutgers Law School Research Paper
Number of pages: 6 Posted: 01 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 178 (215,231)

Abstract:

Loading...

antitrust, Rule of Reason, balancing

The Four-Step Rule of Reason

33 Antitrust 50 (2019)
Number of pages: 6 Posted: 23 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 20 (672,181)
Citation 1

Abstract:

Loading...

antitrust, Rule of Reason, O'Bannon, Amex

53.

Eight Reasons Why 'No-Authorized-Generic' Promises Constitute Payment

67 Rutgers University Law Review 697 (2015)
Number of pages: 24 Posted: 05 Dec 2014 Last Revised: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 192 (201,259)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, authorized generics, Lamictal, Loestrin

54.

Brief Amici Curiae of 82 Law, Economics, Business, and Medical Professors in Support of Respondent

U.S. Court of Appeals for the Fifth Circuit, 2019
Number of pages: 43 Posted: 16 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 187 (206,081)

Abstract:

Loading...

patent, antitrust, Actavis, pay-for-delay, reverse payment, settlement, Impax

55.

A US Court Issues Second Ruling Determining RAND Rate for Standard Essential Patent (Innovatio)

e-Competitions Bulletin, No 58558, 2013
Number of pages: 6 Posted: 24 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 181 (212,061)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP, WiFi

56.

Provigil: A Case Study of Anticompetitive Behavior

Hastings Science & Technology Law Journal, Vol. 3, No. 2, pp. 441-452, Summer 2011
Number of pages: 12 Posted: 15 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 176 (217,266)

Abstract:

Loading...

patent, antitrust, settlements, product hopping, drugs, Hatch Waxman, Provigil, Cephalon

57.

What Is Trump Antitrust?

Concurrences, No. 4, 2016
Number of pages: 26 Posted: 01 Dec 2016
Microsoft Corporation, Sheppard, Mullin, Richter & Hampton LLP, Axinn Veltrop & Harkrider, LLP, George Mason University - Mercatus Center, Orrick, Herrington & Sutcliffe, LLP, American Antitrust Institute (AAI), Dechert LLP, Hogan Lovells, Hogan Lovells, Qualcomm, Inc., Bingham McCutchen, LLP, Paul, Weiss, Rifkind, Wharton & Garrison LLP, Skadden, Arps, Slate, Meagher & Flom LLP, General Electric Company, University of California, Berkeley - Department of Economics, Northeastern University - Department of Economics, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Loyola University Chicago School of LawNavigant Consulting, Inc., Willkie Farr & Gallagher LLP, Willkie Farr & Gallagher LLP, Rutgers Law School, Hausfeld, Hausfeld and Hausfeld
Downloads 171 (222,678)

Abstract:

Loading...

United States, Antitrust Policy, Presidential Election, Mergers, Cartels, Monopolization, International Cooperation, European Union

58.

O’Bannon v. National Collegiate Athletic Association: Why the Ninth Circuit Should Not Block the Floodgates of Change in College Athletics

71 Wash. & Lee L. Rev. Online 299, Cleveland-Marshall Legal Studies Paper No. 2575764
Number of pages: 13 Posted: 10 Mar 2015
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 171 (222,678)

Abstract:

Loading...

NCAA, O'Bannon, college sports, right of publicity, antitrust, rule of reason, amateurism, less restrictive alternatives

59.

A Non-Coercive Approach to Product Hopping

33 Antitrust 102 (2018), Rutgers Law School Research Paper
Number of pages: 6 Posted: 16 Jan 2019
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 169 (224,844)

Abstract:

Loading...

product hopping, pharmaceuticals, antitrust, drugs, innovation

60.

Innovation for the 21st Century: A Response to Seven Critics

61 Alabama Law Review, Vol. 61, p. 597, 2010
Number of pages: 31 Posted: 11 Oct 2009 Last Revised: 30 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 169 (224,844)

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

61.

Why Modularity Does Not (and Should Not) Explain Intellectual Property

Yale Law Journal Pocket Part, Vol. 117, p. 95, 2007
Number of pages: 6 Posted: 04 Feb 2008
Michael A. Carrier
Rutgers Law School
Downloads 167 (227,136)

Abstract:

Loading...

intellectual property, property, modularity, patents, copyrights

62.

How Not to Apply Actavis

Northwestern University Law Review Online, Vol. 109, 2014
Number of pages: 18 Posted: 16 Nov 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 164 (230,668)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, Lamictal, Loestrin, reverse payments, exclusion payments

63.

Why a 'Large and Unjustified' Payment Threshold is Not Consistent with Actavis

91 Washington Law Review 109 (2016)
Number of pages: 10 Posted: 23 Sep 2015 Last Revised: 05 Apr 2016
Michael A. Carrier
Rutgers Law School
Downloads 159 (236,803)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, large and unjustified payment, reverse payments, exclusion payments, Rule of Reason

64.

U.S. Court Finds that an Athletics Association's Rules Restricting Payments to Student-Athletes Violate Antitrust Laws (O’Bannon v. NCAA)

e-Competitions Bulletin, No. 68725, Sept. 2014
Number of pages: 8 Posted: 19 Sep 2014
Michael A. Carrier
Rutgers Law School
Downloads 159 (236,803)

Abstract:

Loading...

sports, antitrust, NCAA, right of publicity

65.

Five Arguments Laid to Rest after Actavis

Antitrust Source, Vol. 13 No. 1 (October 2013)
Number of pages: 11 Posted: 06 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 149 (249,791)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, patent scope

66.

A Response to Chief Justice Roberts: Why Antitrust Must Play a Role in the Analysis of Drug Patent Settlements

15 Minnesota Journal of Law, Science & Technology 31 (2014)
Number of pages: 10 Posted: 22 Sep 2013 Last Revised: 08 Mar 2014
Michael A. Carrier
Rutgers Law School
Downloads 147 (252,553)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

67.

The US Supreme Court Issues First Ruling on Antitrust Legality of Reverse-Payment Drug Patent Settlements (Actavis)

e-Competitions Bulletin, No. 53120, July 2013
Number of pages: 6 Posted: 16 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 145 (255,380)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, Hatch Waxman, brands, generics

68.

The Business of Amateurs: Suffering Student-Athletes and a Thriving NCAA

Number of pages: 2 Posted: 13 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 144 (256,792)

Abstract:

Loading...

sports, college, NCAA, football, basketball, amateurism

69.

Pictures at the New Economy Exhibition: Why the Antitrust Modernization Commission Got it (Mostly) Right

38 Rutgers Law Journal 473 (2007)
Number of pages: 20 Posted: 09 Jul 2007 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 143 (258,211)

Abstract:

Loading...

antitrust, new economy, Antitrust Modernization Commission (AMC), intellectual property, patents, innovation

70.

The Neglected Concern of Firm Size in Pharmaceutical Mergers

84 Antitrust Law Journal (forthcoming 2021), Rutgers Law School Research Paper No. Forthcoming
Number of pages: 26 Posted: 18 Feb 2021 Last Revised: 20 Sep 2021
Patricia M. Danzon, Patricia M. Danzon and Michael A. Carrier
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Rutgers Law School
Downloads 138 (265,658)

Abstract:

Loading...

pharmaceutical industry, mergers, acquisitions, antitrust, divestitures

71.

Brief Amici Curiae of 53 Law, Economics, and Business Professors, the American Antitrust Institute, and Consumers Union in Support of Appellants

Third Circuit brief in In re: Lamictal Direct Purchaser Antitrust Litigation, 2014
Number of pages: 41 Posted: 29 Apr 2014
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 137 (267,214)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Lamictal

72.

A US Court Issues Formalistic Ruling on Reverse-Payment Settlements After 'Actavis' (GlaxoSmithKline/Teva Pharmaceuticals/Louisiana Wholesale Drug Company/King Drug Company)

e-Competitions Bulletin, No. 63588, February 2014
Number of pages: 5 Posted: 17 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 135 (270,300)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, patent, antitrust, Actavis, Hatch Waxman, brands, generics, authorized generics

73.

The Rule of Reason in the Post-Actavis World

2018 Columbia Business Law Review 26
Number of pages: 20 Posted: 23 May 2018
Michael A. Carrier
Rutgers Law School
Downloads 134 (271,819)

Abstract:

Loading...

settlements, pharmaceuticals, drugs, Actavis, Taft, Rule of Reason, O'Bannon, Addyston Pipe, Wellbutrin

74.

High Prices & No Excuses: 6 Anticompetitive Games (Presentation Slides)

Testimony for FTC Workshop on “Understanding Competition in Prescription Drug Markets”, 2017
Number of pages: 10 Posted: 08 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 133 (273,368)

Abstract:

Loading...

Drugs, Pharmaceuticals, Patent, Antitrust

75.

Five Actions to Stop Citizen Petition Abuse

118 Columbia Law Review Online 81 (2018)
Number of pages: 12 Posted: 28 Sep 2017 Last Revised: 09 Mar 2018
Michael A. Carrier
Rutgers Law School
Downloads 130 (277,959)

Abstract:

Loading...

citizen petitions, pharmaceuticals, drugs, FDA

76.

Rescuing Antitrust’s Role in Patent Holdup

168 U. Pa. L. Rev. Online 238 (2021)
Number of pages: 15 Posted: 19 Jun 2020 Last Revised: 24 Feb 2021
Michael A. Carrier
Rutgers Law School
Downloads 129 (279,606)

Abstract:

Loading...

standards, patents, antitrust, holdup

77.

Only 'Scraping' the Surface: The Copyright Hole in the FTC's Google Settlement

46 UBC Law Review (2013)
Number of pages: 19 Posted: 07 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 128 (281,185)

Abstract:

Loading...

copyright, antitrust, Google, scraping, fair use, misappropriation, Yelp, reviews

78.

Four Innovation Myths

Concurrences (Albert A. Foer Liber Amicorum), Forthcoming, Rutgers Law School Research Paper No. Forthcoming
Number of pages: 25 Posted: 22 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 124 (288,026)

Abstract:

Loading...

innovation, patent holdup, FRAND, cumulative innovation, innovation markets, statutory damages

79.

The Curious Case of Wellbutrin: How the Third Circuit Mistook Itself for the Supreme Court

103 Cornell L. Rev. Online 137 (2018)
Number of pages: 12 Posted: 29 Aug 2017 Last Revised: 17 Apr 2018
Michael A. Carrier
Rutgers Law School
Downloads 123 (289,715)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, drugs, settlements, reverse payments, risk aversion, Wellbutrin

80.

When is the Senate in Recess for Purposes of the Recess Appointments Clause?

Michigan Law Review, Vol. 92, No. 7, 1994
Number of pages: 44 Posted: 12 Jul 2007
Michael A. Carrier
Rutgers Law School
Downloads 120 (294,947)

Abstract:

Loading...

Recess Appointments Clause, recess, intersession, intrasession

81.

Brief of International Intellectual Property Law Professors as Amici Curiae in Support of Neither Party - Ericsson v. Samsung

University of Utah College of Law Research Paper No. 425
Number of pages: 40 Posted: 11 Mar 2021 Last Revised: 20 Mar 2021
University of Utah - S.J. Quinney College of Law, Franklin Pierce Center for IP at UNH Law, Rutgers Law School, DePaul University College of Law and Texas A&M University School of Law
Downloads 119 (296,677)

Abstract:

Loading...

patent, anti-suit injunction, FRAND, standards, comity, China

82.

Brief of Thirty-Four Law Professors as Amici Curiae in Support of Appellants in Altera Corp. v. Papst Licensing GMBH

Southwestern Law School Research Paper No. 2015-25
Number of pages: 28 Posted: 22 Dec 2015 Last Revised: 06 Jan 2021
Southwestern Law School, University at Buffalo Law School, Tulane University Law School, Creighton University School of Law, Yeshiva University - Benjamin N. Cardozo School of Law, Rutgers Law School, University of Denver Sturm College of Law, Santa Clara University - School of Law, University of Utah - S.J. Quinney College of Law, UC Hastings Law, University of Kentucky - College of Law, Elon University School of Law, University of California, Davis, University of New Hampshire Franklin Pierce School of Law, Suffolk University Law School, Temple University - James E. Beasley School of Law, Emory University, University of Baltimore - School of Law, University of Houston Law CenterUniversity of Houston Law Center, Catholic University of America (CUA) - Columbus School of Law, Stanford Law School, UC Hastings Law, University of Georgia School of Law, St. Thomas University School of Law, St. Thomas University School of Law, Indiana University Robert H. McKinney School of Law, Center for Intellectual Property & Innovation, Michigan State University College of Law, South Texas College of Law, Case Western Reserve University School of Law, Washington and Lee University School of Law, University of St. Thomas School of Law (Minnesota), Florida International University (FIU) - College of Law, Simpson Thacher & Bartlett LLP and University of Pennsylvania Carey Law School - Student/Alumni/Adjunct
Downloads 119 (296,677)

Abstract:

Loading...

patent, declaratory judgment, jurisdiction, personal jurisdiction, patent assertion entity, minimum contacts

83.

The Alston Case: Why the NCAA Did not Deserve Antitrust Immunity and Did not Succeed under a Rule-of-Reason Analysis

28 George Mason Law Review 1461 (2021)
Number of pages: 26 Posted: 30 Aug 2021
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 109 (315,605)

Abstract:

Loading...

NCAA, student-athletes, antitrust, amateurism, Alston

84.

Brief of Amici Curiae 49 Professors in Support of Petitioners

California Supreme Court brief in In re Cipro Cases I & II, 2014
Number of pages: 47 Posted: 19 Mar 2014
Michael A. Carrier and Judith Zahid
Rutgers Law School and Zelle Hofmann Voelbel & Mason LLP
Downloads 108 (317,579)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

85.

Corrected Brief of Amici Curiae Fifty-Seven Law, Economics, Business, Health, and Medicine Professors in Support of Cross-Appellant's Petition for Rehearing En Banc

Federal Circuit brief in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.
Number of pages: 34 Posted: 23 Dec 2020 Last Revised: 04 Jan 2021
Michael A. Carrier, Matthew J Dowd and Robert Scheffel
Rutgers Law School, Dowd Scheffel PLLC and affiliation not provided to SSRN
Downloads 106 (321,660)

Abstract:

Loading...

patent, skinny label, section viii, Hatch-Waxman Act, generics

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit brief in In re: Effexor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 18 Nov 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 59 (457,905)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Effexor

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit Brief In re: Lipitor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 29 Dec 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 43 (527,225)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, damages forgiveness, Hatch Waxman Act, Lipitor

87.

The US Federal Trade Commission Issues Report on Patent Assertion Entities

e-Competitions Bulletin, No. 82367, December 2016
Number of pages: 7 Posted: 12 Jan 2017
Michael A. Carrier
Rutgers Law School
Downloads 100 (334,289)

Abstract:

Loading...

PAE, Patent Assertion Entity, Troll, FTC, Antitrust, Patent

88.

Amici Curiae Brief of 66 Law, Economics, Business, and Medical Professors in Support of Plaintiffs-Appellants

Seventh Circuit brief in UFCW Local 1500 Welfare Fund v. AbbVie Inc., Rutgers Law School Research Paper No. Forthcoming
Number of pages: 35 Posted: 09 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 97 (340,915)

Abstract:

Loading...

antitrust, patent, thicket, Humira, settlement, pay for delay, sham litigation

89.

Brief of Amici Curiae 65 Professors of Law, Business, Economics, and Sports Management in Support of Respondents

Supreme Court brief in NCAA v. Alston and American Athletic Conference v. Alston, Rutgers Law School Research Paper
Number of pages: 49 Posted: 10 Mar 2021
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 95 (345,476)

Abstract:

Loading...

NCAA, College Sports, Amateurism, Antitrust, Rule of Reason, Antitrust Immunity, Board of Regents

90.

Pay-for-Delay: Who Does the Generic Industry Lobby Represent?

CPI Antitrust Chronicle, May 2020
Number of pages: 10 Posted: 28 May 2020
Michael A. Carrier
Rutgers Law School
Downloads 95 (345,476)

Abstract:

Loading...

Generics, AAM, Pay-for-Delay, Reverse-Payment Settlements, Impax, AB 824

91.

What Does State Law Say About Drug Patent Settlements? The California Supreme Court's Cipro Case

Antitrust Health Care Chronicle (April 2015)
Number of pages: 12 Posted: 21 Apr 2015
Michael A. Carrier
Rutgers Law School
Downloads 95 (345,476)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

92.

2025: Reverse-Payment Settlements Unleashed

Competition Policy International Antitrust Journal, Vol. 2, December 2010
Number of pages: 5 Posted: 16 Jan 2011
Michael A. Carrier
Rutgers Law School
Downloads 94 (347,821)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, reverse payments, Hatch Waxman

93.

Don’t Die! How Biosimilar Disparagement Violates Antitrust Law

115 Northwestern University Law Review Online 119 (2020)
Number of pages: 27 Posted: 27 May 2020 Last Revised: 04 Mar 2021
Michael A. Carrier
Rutgers Law School
Downloads 93 (350,189)

Abstract:

Loading...

Pharmaceuticals, Drugs, Biosimilars, Biologics, Disparagement, Antitrust

94.

A U.S. Court Sends Second Reverse-Payment Case to Trial (Cephalon)

e-Competitions Bulletin, No. 71871, January 2015
Number of pages: 5 Posted: 24 Mar 2015
Michael A. Carrier
Rutgers Law School
Downloads 92 (352,595)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, "large and unjustified," settlement, reverse payments, exclusion payments, Cephalon

95.

Reverse-Payment Settlement Agreements Roundtable

ABA Antitrust Health Care Chronicle, 2013
Number of pages: 21 Posted: 13 Apr 2013 Last Revised: 05 May 2015
Michael A. Carrier, Howard Morse, Eric Stock, Kent Bernard and Karen Bokat
Rutgers Law School, Cooley Godward Kronish LLP, Hogan Lovells, Fordham University School of Law and Wiley Rein & Fielding LLP
Downloads 92 (352,595)

Abstract:

Loading...

drug patents, reverse payments, settlements, patent, antitrust, pharmaceuticals, Hatch Waxman Act

96.

College Athletics: The Chink in the Seventh Circuit's 'Law and Economics' Armor

117 Michigan Law Review Online 90 (2019), Rutgers Law School Research Paper
Number of pages: 14 Posted: 26 Feb 2019 Last Revised: 12 Nov 2019
Michael A. Carrier and Marc Edelman
Rutgers Law School and City University of New York - Baruch College, Zicklin School of Business
Downloads 90 (357,496)

Abstract:

Loading...

NCAA, College Sports, Antitrust, Amateurism, Student-Athletes, Rule of Reason

97.

Limiting Copyright Through Property

Forthcoming in Concepts of Property in Intellectual Property (Cambridge 2013)
Number of pages: 17 Posted: 25 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 89 (359,983)

Abstract:

Loading...

copyright, property, propertization, rights

98.

2008 and 2015: Night and Day for Drug Patent Settlements

CPI Antitrust Chronicle, Dec. 2015
Number of pages: 8 Posted: 16 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 88 (362,553)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, scope-of-patent, Actavis, Lamictal, Cipro, Cephalon, FTC, reverse payments, exclusion payments

99.

The U.S. District Court for the Northern District of Illinois Dismisses Antitrust Case Challenging Patent Thicket (Humira)

e-Competitions (No. 96364, Sept. 2020)
Number of pages: 7 Posted: 10 Sep 2020 Last Revised: 28 Nov 2020
Michael A. Carrier
Rutgers Law School
Downloads 86 (367,718)

Abstract:

Loading...

antitrust, patent thicket, settlement, sham, injury, Humira

100.

The NCAA's Exploitation of Student-Athletes

Sports Law Blog, 2016
Number of pages: 2 Posted: 24 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 84 (372,982)

Abstract:

Loading...

NCAA, amateurism, student-athlete

101.

Front Matter and Introduction to: Intellectual Property and Competition

Edward Elgar Publishing, 2011
Number of pages: 20 Posted: 18 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 81 (381,128)

Abstract:

Loading...

antitrust, competition, intellectual property

102.

Brief Amici Curiae of 58 Law, Economics, and Business Professors in Support of Appellants' Petition for Panel Rehearing or Rehearing En Banc

Third Circuit brief in In re Wellbutrin XL Antitrust Litigation, 2017
Number of pages: 23 Posted: 07 Sep 2017
Michael A. Carrier
Rutgers Law School
Downloads 79 (386,692)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, risk aversion, Actavis, Wellbutrin

103.

How Biosimilar Disparagement Violates Antitrust Law

Bloomberg Law (Nov. 16, 2020)
Number of pages: 3 Posted: 23 Dec 2020
Michael A. Carrier
Rutgers Law School
Downloads 76 (395,291)

Abstract:

Loading...

Pharmaceuticals, Drugs, Biosimilars, Biologics, Disparagement, Antitrust

104.

The U.S. Court of Appeals for the First Circuit Concludes that a Reverse Payment Need Not Be in Cash (Loestrin)

e-Competitions Bulletin, No. 78533, March 2016
Number of pages: 5 Posted: 21 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 75 (398,257)

Abstract:

Loading...

antitrust, patent, Hatch Waxman, drugs, pharmaceuticals, reverse payments, pay for delay

105.

Limelight v. Akamai: Limiting Induced Infringement

Wisconsin Law Review online, 2014:1
Number of pages: 8 Posted: 22 Jul 2014
Michael A. Carrier
Rutgers Law School
Downloads 74 (401,269)

Abstract:

Loading...

patent, inducement, infringement, Akamai, Limelight, Federal Circuit

106.

Actavis and 'Large and Unjustified' Payments

SCOTUSblog, 2013
Number of pages: 5 Posted: 30 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 73 (404,319)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, pay for delay

107.

The U.S. Court of Appeals for the Third Circuit Concludes that the Actavis Ruling Applies to Non-Cash Payments (Lamictal)

e-Competitions Bulletin, No. 75208, August 2015
Number of pages: 4 Posted: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 72 (407,367)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, authorized generics, Hatch Waxman, brands, generics

108.

A Six-Step Solution to the PBM Problem

Health Affairs Blog, Aug. 30, 2018
Number of pages: 3 Posted: 12 Oct 2018
Michael A. Carrier
Rutgers Law School
Downloads 71 (410,543)

Abstract:

Loading...

PBM, pharmacy benefit manager, drug pricing, rebates

109.

Increasing Innovation Through Copyright Common Sense and Better Government Policy

Emory Law Journal, Vol. 62, No. 983, 2013
Number of pages: 15 Posted: 03 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 71 (410,543)

Abstract:

Loading...

innovation, copyright, immigration, tax, STEM, statutory damages, personal liability, R&D tax credit, basic research

110.

Foreword: After Actavis: Seven Ways Forward

67 Rutgers University Law Review 543 (2015)
Number of pages: 13 Posted: 09 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 70 (413,592)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, Actavis, drug patent settlements, reverse payments, Actavis inference, jury instructions, authorized generics, Cipro, Noerr-Pennington

111.

Copyright and Innovation: Responses to Marks, Masnick, and Picker

2013 Wisconsin Law Review Online
Number of pages: 16 Posted: 12 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 70 (413,592)

Abstract:

Loading...

copyright, innovation, creativity, music, record labels, napster, peer-to-peer (p2p)

112.

Brief Amici Curiae on Behalf of 70 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

First Circuit brief in In re: Loestrin 24 FE Antitrust Litigation, 2015
Number of pages: 45 Posted: 17 Jun 2015
Michael A. Carrier and Kenneth Wexler
Rutgers Law School and Wexler Wallace LLP
Downloads 69 (416,860)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Loestrin

113.

Statement by Michael A. Carrier to Senate Judiciary Committee on 'Intellectual Property and the Price of Prescription Drugs: Balancing Innovation and Competition'

Senate Judiciary Committee hearing May 7, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 06 Sep 2019
Michael A. Carrier
Rutgers Law School
Downloads 65 (430,121)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, sample denials, pay-for-delay settlements, citizen petitions, product hopping, patent thickets

114.

The Industry that Cries Wolf: Pharma and Innovation

STAT: First Opinion, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 28 Oct 2019
Michael A. Carrier and Genevieve Tung
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 64 (433,579)

Abstract:

Loading...

pharmaceuticals, drugs, innovation

115.

The U.S. Court of Appeals for Third Circuit Offers Misguided Analysis of Product Hopping

e-Competitions Bulletin, No. 81744, October 2016
Number of pages: 6 Posted: 31 Oct 2016
Michael A. Carrier
Rutgers Law School
Downloads 63 (437,055)

Abstract:

Loading...

Product Hopping, Drugs, Pharmaceuticals, Antitrust, Patent, Regulation, Doryx, Mylan, Warner Chilcott

116.

Four Proposals to Enhance Generic Competition (Presentation Slides)

FDA Testimony (2017)
Number of pages: 9 Posted: 18 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 60 (447,618)

Abstract:

Loading...

pharmaceuticals, drugs, generics, patents, REMS, citizen petitions, Hatch Waxman

117.

The California Supreme Court Cements Vigorous Scrutiny of Reverse-Payment Settlements (Cipro)

e-Competitions Bulletin, No. 73830, June 2015
Number of pages: 6 Posted: 09 Jul 2015
Michael A. Carrier
Rutgers Law School
Downloads 59 (451,299)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, state antitrust law, Cartwright Act

118.

The U.S. District Court for the Northern District of California Sets Student-Athletes' Antitrust Case for Trial (NCAA)

e-Competitions Bulletin, No. 87066, May 2018
Number of pages: 5 Posted: 12 Jun 2018
Michael A. Carrier
Rutgers Law School
Downloads 56 (462,507)
Citation 1

Abstract:

Loading...

Sports, antitrust, NCAA, amateurism, Jenkins, O'Bannon, Rule of Reason

119.

Antitrust after the Interception: Of a Heroic Returner and Myriad Paths

Stanford Law Review, Vol. 55, October 2002
Number of pages: 15 Posted: 04 Dec 2002
Michael A. Carrier
Rutgers Law School
Downloads 53 (474,005)

Abstract:

Loading...

120.

FTC Reverses Administrative Law Judge Decision, Finding Section 5 Violation for Reverse-Payment Settlement (Impax)

e-Competitions Bulletin, No. 90331, May 2019, Rutgers Law School Research Paper
Number of pages: 9 Posted: 29 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 51 (482,120)

Abstract:

Loading...

pharmaceuticals, drugs, settlements, reverse payment, Impax, FTC, Commission

121.

REMS Patents Should Not be Listed in Orange Book

FDA Request for Comment on Listing of Patent Information in Orange Book, 2020
Number of pages: 1 Posted: 10 Sep 2020
Michael A. Carrier
Rutgers Law School
Downloads 50 (486,235)

Abstract:

Loading...

REMS patents, Orange Book

122.

U.S. Court Issues Concerning Ruling on Drug Patent Settlements (Loestrin)

e-Competitions Bulletin, No. 69705, October 2014
Number of pages: 5 Posted: 05 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 50 (486,235)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, Loestrin

123.

Brief Amici Curiae of the American Antitrust Institute and Consumers Union

ED Pa Brief in In re: Wellbutrin XL Antitrust Litigation
Number of pages: 34 Posted: 02 Oct 2013
Michael A. Carrier
Rutgers Law School
Downloads 50 (486,235)

Abstract:

Loading...

patent, antitrust, settlement, authorized generics, drugs, pharmaceuticals, Hatch Waxman, reverse payment, exclusive license

124.

Responses to Questions for the Record by Senators Grassley, Klobuchar, and Blumenthal for Senate Judiciary Committee Hearing on 'IP and the Price of Prescription Drugs: Balancing Innovation and Competition'

Responses to Questions for the Record by Senator Grassley, Senator Klobuchar, and Senator Blumenthal, Rutgers Law School Research Paper
Number of pages: 9 Posted: 06 Sep 2019
Michael A. Carrier
Rutgers Law School
Downloads 48 (494,699)

Abstract:

Loading...

pharmaceuticals, drugs, PBMs, patent examination, citizen petitions, product hopping, patent thicketing, killer acquisitions

125.

Brief for the American Antitrust Institute As Amicus Curiae in Support of Petition for Rehearing and Rehearing En Banc

U.S. Court of Appeals for Third Circuit
Number of pages: 16 Posted: 20 Oct 2016
Michael A. Carrier and Richard Brunell
Rutgers Law School and affiliation not provided to SSRN
Downloads 48 (494,699)

Abstract:

Loading...

product hopping, antitrust, patent, drugs, pharmaceuticals, Mylan, Warner Chilcott, Namenda

126.

Why the Supreme Court Should Deny Certiorari in King Drug

CPI Antitrust Chronicle (Sept. 2016)
Number of pages: 8 Posted: 24 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 48 (494,699)
Citation 1

Abstract:

Loading...

settlements, patent, antitrust, Actavis, pharmaceuticals, drugs, reverse payments, exclusive license

Statement by Michael A. Carrier to Health Subcommittee of House Committee on Energy & Commerce

House Subcommittee of House Committee on Energy & Commerce hearing March 13, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 14 Mar 2019
Michael A. Carrier
Rutgers Law School
Downloads 39 (547,644)

Abstract:

Loading...

Pharmaceuticals, Drugs, Antitrust, Samples, Settlements, Orange Book, Purple Book

Statement by Michael A. Carrier to Health Subcommittee of House Committee on Energy & Commerce

Health Subcommittee of House Committee on Energy & Commerce hearing, May 4, 2021
Number of pages: 4 Posted: 22 Jun 2021
Michael A. Carrier
Rutgers Law School
Downloads 8 (772,222)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, pay-for-delay settlements, citizen petitions

128.

The U.S. Court of Appeals for the Third Circuit Applies an Appropriate Post-Actavis Pleading Standard (Lipitor)

e-Competitions Bulletin, No. 84937, October 2017
Number of pages: 9 Posted: 20 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 47 (499,098)

Abstract:

Loading...

Drugs, Patents, Settlements, Pleading, Actavis, Lipitor, Effexor

129.

Eliminate Statutory Damages for Secondary Infringers

Department of Commerce Internet Policy Task Force Comment, 2014, Innovation for the 21st Century paperback, Oxford University Press, USA, 2011
Number of pages: 19 Posted: 17 Jan 2014 Last Revised: 19 Jan 2014
Michael A. Carrier
Rutgers Law School
Downloads 45 (507,867)

Abstract:

Loading...

copyright, statutory damages, innovation, secondary liability

130.

Don't Ditch Antitrust's Role in Product Hopping: A Response to Pace and Adam

33 Antitrust 72 (2019), Rutgers Law School Research Paper
Number of pages: 2 Posted: 28 Apr 2019
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 42 (521,590)

Abstract:

Loading...

antitrust, product hopping, pharmaceuticals, drugs, innovation

131.

Statement by Michael A. Carrier to Senate Judiciary Committee

Senate Judiciary Committee hearing May 7, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 29 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 41 (526,272)

Abstract:

Loading...

drugs, pharmaceuticals, antitrust, samples, settlements, citizen petitions, product hopping, patent thicketing

132.

IP and Competition: Context, Test, and Balance

Comment for FTC Hearings on Competition and Consumer Protection in the 21st Century
Number of pages: 1 Posted: 27 Aug 2018
Michael A. Carrier
Rutgers Law School
Downloads 41 (526,272)

Abstract:

Loading...

IP, competition, FTC, pharmaceuticals, consumer welfare, patent holdup

133.

Addressing Abusive Citizen Petitions

FDA Request for Comments on Citizen Petitions, 2018
Number of pages: 1 Posted: 12 Nov 2018
Michael A. Carrier
Rutgers Law School
Downloads 40 (531,134)

Abstract:

Loading...

citizen petitions, section 505(q), FTC, Congress, generics

134.

Motion for Leave to File Brief and Brief Amicus Curiae in Support of Defendant's Opposition to Plaintiff's Motion for Preliminary Injunction

U.S. District Court for the Eastern District of California, 2019
Number of pages: 24 Posted: 09 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 39 (536,049)

Abstract:

Loading...

drug patent settlements, reverse payments, AB 824, California statute

135.

Answer to Iancu's SEP Policy Call Is in Plain Sight

Law 360, Forthcoming, Rutgers Law School Research Paper
Number of pages: 4 Posted: 08 Oct 2019
Michael A. Carrier
Rutgers Law School
Downloads 39 (536,049)

Abstract:

Loading...

standards, patents, antitrust

136.

How Biologics Cos. Disparage Biosimilars And How To Stop It

Law360 (Aug. 4, 2020)
Number of pages: 4 Posted: 10 Sep 2020
Michael A. Carrier
Rutgers Law School
Downloads 37 (546,132)

Abstract:

Loading...

biologics, biosimilars, disparagement

137.

Statement by Michael A. Carrier to House Judiciary Committee on 'Antitrust Concerns and the FDA Approval Process'

House Judiciary Committee hearing, July 24, 2017
Number of pages: 3 Posted: 26 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 37 (546,132)

Abstract:

Loading...

antitrust, patent, drugs, pharmaceuticals, REMS, CREATES Act, settlements, citizen petitions

138.

The 'Equity of the Statute' and Copyright Law: Three Critiques

163 University of Pennsylvania Law Review Online 377 (2015)
Number of pages: 16 Posted: 04 Dec 2015 Last Revised: 09 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 37 (546,132)

Abstract:

Loading...

copyright, equity, incentives, access, Kirtsaeng, Feist, Harper & Row, Reed Elsevier, Fogerty, Petrella, Sony, Grokster, Aereo

139.

Why Property Law Does Not Support the Antitrust Abandonment of Standards

57 Houston Law Review 265 (2019)
Number of pages: 20 Posted: 16 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 36 (551,347)

Abstract:

Loading...

antitrust, patent holdup, standards, property, FRAND

140.

Statement by Michael A. Carrier to House Judiciary Committee (Subcommittee on Antitrust, Commercial and Administrative Law)

House Subcommittee of House Judiciary Committee hearing, April 27, 2021
Number of pages: 10 Posted: 22 Jun 2021
Michael A. Carrier
Rutgers Law School
Downloads 35 (556,616)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, product hopping, pay-for-delay settlements, citizen petitions, biosimilars, consolidation

141.

4 Ways Kanter Should Clean Up DOJ Antitrust Holdups

Law 360 (November 17, 2021)
Number of pages: 6 Posted: 18 Nov 2021
Michael A. Carrier
Rutgers Law School
Downloads 33 (567,443)

Abstract:

Loading...

standards, antitrust, holdup, patents

142.

Comments on Proposed Update on Intellectual Property Licensing Guidelines

Number of pages: 1 Posted: 03 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 32 (572,882)

Abstract:

Loading...

intellectual property, agencies, regulation, industry, patents

143.

Why the New Administration Should Bury the New Madison Approach

CPI Antitrust Chronicle (July 2021)
Number of pages: 10 Posted: 17 Aug 2021
Michael A. Carrier
Rutgers Law School
Downloads 30 (584,301)

Abstract:

Loading...

standards, antitrust, patents

144.

Five Proposals to Stop the Games and Encourage a Robust Biosimilar Market

FDA Request for Comments on Biologics Marketplace, 2018
Number of pages: 1 Posted: 12 Oct 2018
Michael A. Carrier
Rutgers Law School
Downloads 29 (590,317)

Abstract:

Loading...

FDA, competition, antitrust, REMS, citizen petitions, FTC

145.

Essential Changes to Shared REMS

Comment to Proposed FDA Regulations, 2018
Number of pages: 1 Posted: 01 Aug 2018
Michael A. Carrier
Rutgers Law School
Downloads 27 (602,704)

Abstract:

Loading...

REMS, Drugs, Pharmaceuticals, Brands, Generics, FDA

146.

Statement by Michael A. Carrier to House Energy & Commerce Committee (Subcommittee on Consumer Protection and Commerce)

House Subcommittee of House Energy & Commerce Committee hearing September 19, 2019 , Rutgers Law School Research Paper
Number of pages: 3 Posted: 22 Oct 2019
Michael A. Carrier
Rutgers Law School
Downloads 26 (609,203)

Abstract:

Loading...

antitrust, pharmaceuticals, drugs, product hopping

147.

Brief Amicus Curiae in Support of Appellee's Answering Brief

U.S. Court of Appeals for the Ninth Circuit, 2020, Rutgers Law School Research Paper
Number of pages: 31 Posted: 06 Mar 2020
Michael A. Carrier
Rutgers Law School
Downloads 25 (615,919)

Abstract:

Loading...

drug patent settlements, reverse payments, AB 824, California statute

148.

Solving the 'Parking' Problem in the Drug Monopoly Game

The Hill (December 2019)
Number of pages: 3 Posted: 02 Jun 2020
Michael A. Carrier
Rutgers Law School
Downloads 23 (629,629)

Abstract:

Loading...

settlements, generics, Hatch-Waxman Act

149.

DOJ Giving Cover to Monopolizing Firms that Breach Antitrust Rules

The Hill (Oct. 11, 2018), Rutgers Law School Research Paper
Number of pages: 3 Posted: 16 Jan 2019
Michael A. Carrier
Rutgers Law School
Downloads 22 (636,686)

Abstract:

Loading...

standards, patents, antitrust, holdup, FRAND

150.

How Standard-Setting Orgs Can Curb Patent Litigation

Law360 (June 15, 2021)
Number of pages: 7 Posted: 04 Oct 2021
Michael A. Carrier and Brian Scarpelli
Rutgers Law School and ACT | The App Association
Downloads 19 (658,043)

Abstract:

Loading...

standards, patents, antitrust, holdup, IEEE

151.

The US Court of Appeals for the Federal Circuit Reverses a Judgment that Upheld 'Skinny Labels' and Allowed a Generic To Launch on Uses Not Covered by a Patent (GlaxoSmithKline/Teva)

e-Competitions (No. 98366, Dec. 2020), Rutgers Law School Research Paper No. Forthcoming
Number of pages: 6 Posted: 12 Feb 2021
Michael A. Carrier
Rutgers Law School
Downloads 18 (665,171)

Abstract:

Loading...

patents, skinny labels, pharmaceuticals, inducement, patent infringement

152.
Downloads 11 (718,616)

Abstract:

Loading...

product hopping, drugs, pharmaceuticals, FTC

153.

Pharmaceutical Antitrust Enforcement in the United States and Chile

Journal of Law and Biosciences 2021
Number of pages: 7 Posted: 17 Aug 2021
Michael A. Carrier and Fernando Araya
Rutgers Law School and Facultad de Derecho Universidad Diego Portales
Downloads 9 (734,374)

Abstract:

Loading...

pay-for-delay settlements, product hopping, FTC, FNE

154.

INSIGHT: New Statement on Standard-Essential Patents Relies on Omissions, Strawmen, Generalities

Bloomberg Law Insight, 2020
Number of pages: 4 Posted: 08 Apr 2020
Michael A. Carrier
Rutgers Law School
Downloads 5 (765,888)

Abstract:

Loading...

Antitrust, Patent, Holdup, Standards, DOJ, PTO, NIST